Type 2 diabetes is one of the most common chronic conditions we see in older adults—and one of the most manageable when ...

The increasing number of people with type 2 diabetes is a major healthcare concern worldwide, especially in the United States. All the food and lifestyle choices you make affect your heart ...

A daily pill for Type 2 diabetes and weight loss is one step closer to transforming lives. Drug-maker Eli Lilly plans to seek regulatory approval for a GLP-1 pill for weight loss this year. The ...

The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients with type 2 diabetes as a complement to diet and exercise. The FDA today ...

Once-daily, oral SGLT2 inhibitor shown to reduce blood sugar and improve glycemic control as an adjunct to diet and exercise MARLBOROUGH, Mass.--(BUSINESS WIRE)--TheracosBio today announced that the U ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Cumulative incidence of noncommunicable diseases was ...

The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control in patients ages 10 and older with type 2 diabetes, used as an adjunct to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Orforglipron conferred HbA1c reductions of 1.3 to 1.6 ...

For Tuesday, Aug. 26, WGN’s Ben Bradley and Lourdes Duarte have the latest on new medical information, including: A daily pill for Type 2 diabetes and weight loss is one step closer to transforming ...